| blood circulation | GO:0008015 | 195 | 0.933 | |
| circulatory system process | GO:0003013 | 197 | 0.900 | |
| striated muscle contraction | GO:0006941 | 45 | 0.899 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.865 | |
| muscle system process | GO:0003012 | 141 | 0.864 | |
| potassium ion transmembrane transport | GO:0071805 | 43 | 0.863 | |
| heart contraction | GO:0060047 | 93 | 0.817 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.803 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.794 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.790 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.772 | |
| heart process | GO:0003015 | 94 | 0.743 | |
| muscle contraction | GO:0006936 | 101 | 0.677 | |
| regulation of system process | GO:0044057 | 200 | 0.673 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.669 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.654 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.632 | |
| cellular potassium ion transport | GO:0071804 | 43 | 0.627 | |
| sarcomere organization | GO:0045214 | 24 | 0.614 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.602 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.602 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.554 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.508 | |
| regulation of cardiac muscle contraction | GO:0055117 | 21 | 0.491 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.487 | |
| organelle assembly | GO:0070925 | 177 | 0.477 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.474 | |
| cation transport | GO:0006812 | 399 | 0.456 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.447 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.444 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.443 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.433 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.412 | |
| regulation of striated muscle contraction | GO:0006942 | 25 | 0.368 | |
| regulation of ion transport | GO:0043269 | 215 | 0.357 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.353 | |
| muscle cell development | GO:0055001 | 133 | 0.347 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.334 | |
| directional locomotion | GO:0033058 | 3 | 0.325 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.320 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.317 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.317 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.310 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.295 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.289 | |
| muscle tissue development | GO:0060537 | 308 | 0.287 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.286 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.286 | |
| potassium ion transport | GO:0006813 | 52 | 0.285 | |
| cardiac muscle cell contraction | GO:0086003 | 7 | 0.267 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.262 | |
| transmembrane transport | GO:0055085 | 412 | 0.248 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.238 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.231 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.228 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.228 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.224 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.218 | |
| myofibril assembly | GO:0030239 | 34 | 0.216 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.210 | |
| cardiac myofibril assembly | GO:0055003 | 12 | 0.203 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.202 | |
| organ growth | GO:0035265 | 117 | 0.201 | |
| regulation of ion transmembrane transporter activity | GO:0032412 | 54 | 0.198 | |
| endocrine system development | GO:0035270 | 98 | 0.194 | |
| heart morphogenesis | GO:0003007 | 178 | 0.185 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.181 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.180 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.178 | |
| regulation of membrane repolarization | GO:0060306 | 7 | 0.178 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.176 | |
| regulation of muscle contraction | GO:0006937 | 49 | 0.174 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.171 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.168 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.163 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.163 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.162 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.161 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.159 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.159 | |
| regulation of ion homeostasis | GO:2000021 | 64 | 0.158 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.158 | |
| regulation of action potential | GO:0098900 | 4 | 0.156 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.154 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.153 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.150 | |
| striated muscle cell development | GO:0055002 | 125 | 0.149 | |
| regulation of potassium ion transport | GO:0043266 | 16 | 0.147 | |
| atrial cardiac muscle cell differentiation | GO:0055011 | 2 | 0.147 | |
| positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway | GO:0010579 | 3 | 0.145 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.144 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.143 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.141 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.138 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.137 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.136 | |
| somitogenesis | GO:0001756 | 69 | 0.133 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.132 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.131 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.129 | |
| positive regulation of transmembrane transport | GO:0034764 | 29 | 0.129 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.127 | |
| regulation of potassium ion transmembrane transport | GO:1901379 | 11 | 0.126 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.126 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.126 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.125 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 32 | 0.125 | |
| positive regulation of camp mediated signaling | GO:0043950 | 3 | 0.125 | |
| extracellular structure organization | GO:0043062 | 148 | 0.125 | |
| cation homeostasis | GO:0055080 | 212 | 0.124 | |
| regulation of cardiac muscle contraction by calcium ion signaling | GO:0010882 | 9 | 0.124 | |
| metanephros development | GO:0001656 | 79 | 0.122 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.122 | |
| response to peptide hormone | GO:0043434 | 127 | 0.120 | |
| regulation of heart rate | GO:0002027 | 36 | 0.118 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.117 | |
| cardiac chamber development | GO:0003205 | 108 | 0.117 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.116 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.114 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.113 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.113 | |
| collagen fibril organization | GO:0030199 | 32 | 0.113 | |
| sodium ion transmembrane transport | GO:0035725 | 49 | 0.112 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.112 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.111 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.110 | |
| cardiac conduction | GO:0061337 | 17 | 0.110 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.109 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.109 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.108 | |
| response to inorganic substance | GO:0010035 | 96 | 0.107 | |
| connective tissue development | GO:0061448 | 179 | 0.106 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.105 | |
| sodium ion transport | GO:0006814 | 73 | 0.105 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.102 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.102 | |
| calcium ion transport | GO:0006816 | 159 | 0.102 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.101 | |
| aortic valve morphogenesis | GO:0003180 | 4 | 0.101 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.099 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.099 | |
| cardiac cell development | GO:0055006 | 41 | 0.098 | |
| visual perception | GO:0007601 | 52 | 0.097 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.097 | |
| rhythmic process | GO:0048511 | 174 | 0.096 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.095 | |
| camera type eye development | GO:0043010 | 266 | 0.093 | |
| atrial cardiac muscle cell development | GO:0055014 | 2 | 0.093 | |
| oxidation reduction process | GO:0055114 | 342 | 0.093 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.093 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.092 | |
| calcium mediated signaling | GO:0019722 | 46 | 0.092 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.092 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.092 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.091 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.091 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.090 | |
| axonogenesis | GO:0007409 | 274 | 0.089 | |
| positive regulation of ion transmembrane transport | GO:0034767 | 24 | 0.089 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.089 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.088 | |
| response to peptide | GO:1901652 | 136 | 0.088 | |
| muscle adaptation | GO:0043500 | 39 | 0.088 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.087 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.085 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.085 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.085 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.084 | |
| ear development | GO:0043583 | 200 | 0.082 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.081 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.080 | |
| microtubule based process | GO:0007017 | 236 | 0.079 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.078 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.078 | |
| cell fate commitment | GO:0045165 | 210 | 0.078 | |
| sa node cell to atrial cardiac muscle cell signalling | GO:0086018 | 4 | 0.077 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.077 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.077 | |
| respiratory system development | GO:0060541 | 190 | 0.076 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.075 | |
| gland development | GO:0048732 | 330 | 0.075 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.074 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.073 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.073 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.073 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.072 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.072 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.072 | |
| visceral serous pericardium development | GO:0061032 | 2 | 0.071 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.070 | |
| cardiac muscle hypertrophy in response to stress | GO:0014898 | 10 | 0.070 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.069 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.068 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.068 | |
| skin development | GO:0043588 | 220 | 0.068 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.068 | |
| response to insulin | GO:0032868 | 100 | 0.067 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.067 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.067 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.067 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.066 | |
| peripheral nervous system neuron axonogenesis | GO:0048936 | 3 | 0.066 | |
| myotube differentiation | GO:0014902 | 105 | 0.066 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.065 | |
| membrane repolarization | GO:0086009 | 7 | 0.065 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.065 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.064 | |
| actin mediated cell contraction | GO:0070252 | 15 | 0.064 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.064 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.064 | |
| bone morphogenesis | GO:0060349 | 78 | 0.063 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.063 | |
| peptide transport | GO:0015833 | 133 | 0.063 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.063 | |
| striated muscle adaptation | GO:0014888 | 26 | 0.063 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.062 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.062 | |
| negative regulation of camp mediated signaling | GO:0043951 | 3 | 0.061 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.061 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.061 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.061 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.061 | |
| response to oxygen levels | GO:0070482 | 62 | 0.060 | |
| positive regulation of cardioblast differentiation | GO:0051891 | 3 | 0.060 | |
| regulation of ras gtpase activity | GO:0032318 | 88 | 0.060 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.060 | |
| positive regulation of calcium ion transport | GO:0051928 | 27 | 0.060 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.060 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.060 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.060 | |
| feeding behavior | GO:0007631 | 62 | 0.059 | |
| response to oxidative stress | GO:0006979 | 123 | 0.059 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.059 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.058 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.058 | |
| stem cell differentiation | GO:0048863 | 268 | 0.058 | |
| positive regulation of potassium ion transmembrane transport | GO:1901381 | 3 | 0.057 | |
| gonad development | GO:0008406 | 141 | 0.057 | |
| sclerotome development | GO:0061056 | 4 | 0.057 | |
| regulation of organ formation | GO:0003156 | 34 | 0.057 | |
| regulation of relaxation of muscle | GO:1901077 | 8 | 0.057 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.056 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.056 | |
| sensory perception of light stimulus | GO:0050953 | 54 | 0.055 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.055 | |
| neuron death | GO:0070997 | 154 | 0.054 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.054 | |
| renal sodium ion transport | GO:0003096 | 2 | 0.054 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.054 | |
| lung development | GO:0030324 | 164 | 0.054 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.054 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.054 | |
| response to starvation | GO:0042594 | 65 | 0.054 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.053 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.053 | |
| positive regulation of mechanoreceptor differentiation | GO:0045633 | 1 | 0.053 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.052 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.052 | |
| positive regulation of potassium ion transport | GO:0043268 | 3 | 0.052 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.052 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.052 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.051 | |
| hormone metabolic process | GO:0042445 | 86 | 0.051 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.051 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.051 | |
| endomembrane system organization | GO:0010256 | 147 | 0.051 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.051 | |
| regulation of secretion | GO:0051046 | 274 | 0.051 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.050 | |
| heart growth | GO:0060419 | 45 | 0.050 | |
| synaptic transmission | GO:0007268 | 329 | 0.050 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.050 | |
| positive regulation of synaptic plasticity | GO:0031915 | 4 | 0.050 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.049 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.049 | |
| respiratory tube development | GO:0030323 | 167 | 0.049 | |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.049 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.049 | |
| urogenital system development | GO:0001655 | 261 | 0.049 | |
| amine metabolic process | GO:0009308 | 45 | 0.048 | |
| forward locomotion | GO:0043056 | 1 | 0.048 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.047 | |
| ureteric bud development | GO:0001657 | 94 | 0.047 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.047 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.047 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.046 | |
| positive regulation of growth | GO:0045927 | 104 | 0.046 | |
| renal system development | GO:0072001 | 225 | 0.046 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.046 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.046 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.046 | |
| response to purine containing compound | GO:0014074 | 28 | 0.045 | |
| response to camp | GO:0051591 | 14 | 0.045 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.045 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.045 | |
| spinal cord development | GO:0021510 | 81 | 0.045 | |
| epithelial tube formation | GO:0072175 | 130 | 0.045 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.045 | |
| regulation of calcium ion transmembrane transporter activity | GO:1901019 | 20 | 0.044 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.044 | |
| regulation of calcium ion transport into cytosol | GO:0010522 | 31 | 0.044 | |
| mitral valve development | GO:0003174 | 4 | 0.044 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.044 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.044 | |
| epithelial cell development | GO:0002064 | 159 | 0.044 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.043 | |
| regionalization | GO:0003002 | 337 | 0.043 | |
| his purkinje system development | GO:0003164 | 4 | 0.043 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.043 | |
| segmentation | GO:0035282 | 93 | 0.043 | |
| bundle of his development | GO:0003166 | 4 | 0.043 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.042 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.042 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.041 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.041 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.041 | |
| cell growth | GO:0016049 | 130 | 0.041 | |
| protein catabolic process | GO:0030163 | 221 | 0.041 | |
| positive regulation of chemotaxis | GO:0050921 | 38 | 0.041 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.040 | |
| response to organophosphorus | GO:0046683 | 22 | 0.040 | |
| developmental maturation | GO:0021700 | 193 | 0.040 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.040 | |
| mitochondrion organization | GO:0007005 | 134 | 0.040 | |
| negative regulation of transmembrane transport | GO:0034763 | 15 | 0.040 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.040 | |
| membrane depolarization | GO:0051899 | 64 | 0.040 | |
| defense response to other organism | GO:0098542 | 197 | 0.040 | |
| ventricular system development | GO:0021591 | 27 | 0.040 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.040 | |
| diencephalon development | GO:0021536 | 63 | 0.039 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.039 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.039 | |
| response to pain | GO:0048265 | 26 | 0.039 | |
| sa node cell action potential | GO:0086015 | 4 | 0.039 | |
| regulation of muscle adaptation | GO:0043502 | 31 | 0.039 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.039 | |
| neural tube formation | GO:0001841 | 108 | 0.039 | |
| locomotory behavior | GO:0007626 | 195 | 0.039 | |
| relaxation of cardiac muscle | GO:0055119 | 9 | 0.038 | |
| tube formation | GO:0035148 | 140 | 0.038 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.038 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.038 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.038 | |
| relaxation of muscle | GO:0090075 | 18 | 0.038 | |
| spermatogenesis | GO:0007283 | 284 | 0.038 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.038 | |
| ossification | GO:0001503 | 216 | 0.038 | |
| neural retina development | GO:0003407 | 41 | 0.038 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.038 | |
| excretion | GO:0007588 | 22 | 0.037 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.037 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.037 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.037 | |
| regulation of tube size | GO:0035150 | 57 | 0.037 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.037 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.037 | |
| multi organism behavior | GO:0051705 | 62 | 0.037 | |
| regulation of neuron death | GO:1901214 | 134 | 0.037 | |
| potassium ion homeostasis | GO:0055075 | 4 | 0.037 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.037 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.036 | |
| neural tube closure | GO:0001843 | 90 | 0.036 | |
| circadian rhythm | GO:0007623 | 114 | 0.036 | |
| negative regulation of growth | GO:0045926 | 99 | 0.036 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.036 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.035 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.035 | |
| cytosolic calcium ion homeostasis | GO:0051480 | 70 | 0.035 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.035 | |
| tissue remodeling | GO:0048771 | 102 | 0.035 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.035 | |
| proepicardium development | GO:0003342 | 2 | 0.034 | |
| transdifferentiation | GO:0060290 | 1 | 0.034 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.034 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.034 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.034 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.034 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.034 | |
| regulation of neurotransmitter transport | GO:0051588 | 35 | 0.034 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.033 | |
| regulation of potassium ion transmembrane transporter activity | GO:1901016 | 7 | 0.033 | |
| regulation of intestinal epithelial structure maintenance | GO:0060730 | 1 | 0.033 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.033 | |
| cell proliferation involved in outflow tract morphogenesis | GO:0061325 | 4 | 0.033 | |
| cell communication involved in cardiac conduction | GO:0086065 | 9 | 0.033 | |
| regulation of ossification | GO:0030278 | 112 | 0.033 | |
| cartilage development | GO:0051216 | 140 | 0.032 | |
| actin filament based movement | GO:0030048 | 23 | 0.032 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.032 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.032 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.032 | |
| l glutamate uptake involved in synaptic transmission | GO:0051935 | 3 | 0.032 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.032 | |
| tube closure | GO:0060606 | 91 | 0.032 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.032 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.032 | |
| clara cell differentiation | GO:0060486 | 4 | 0.032 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.032 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.032 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.031 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.031 | |
| his purkinje system cell differentiation | GO:0060932 | 2 | 0.031 | |
| regulation of calcium ion transmembrane transport | GO:1903169 | 20 | 0.031 | |
| water homeostasis | GO:0030104 | 27 | 0.031 | |
| regulation of the force of heart contraction | GO:0002026 | 17 | 0.031 | |
| regulation of mast cell differentiation | GO:0060375 | 3 | 0.031 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.031 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.031 | |
| pallium development | GO:0021543 | 120 | 0.031 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.031 | |
| cytosolic calcium ion transport | GO:0060401 | 48 | 0.031 | |
| oviduct development | GO:0060066 | 3 | 0.031 | |
| digestive tract development | GO:0048565 | 190 | 0.031 | |
| regulation of cardiac muscle cell contraction | GO:0086004 | 11 | 0.030 | |
| cellular homeostasis | GO:0019725 | 240 | 0.030 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.030 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.030 | |
| positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:2000764 | 1 | 0.030 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.030 | |
| fear response | GO:0042596 | 33 | 0.030 | |
| mesenchyme development | GO:0060485 | 152 | 0.030 | |
| positive regulation of semaphorin plexin signaling pathway | GO:2001262 | 1 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.030 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.030 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.029 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.029 | |
| peptide secretion | GO:0002790 | 114 | 0.029 | |
| cell differentiation in hindbrain | GO:0021533 | 24 | 0.029 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.029 | |
| maintenance of location | GO:0051235 | 89 | 0.029 | |
| response to glucagon | GO:0033762 | 3 | 0.029 | |
| head morphogenesis | GO:0060323 | 34 | 0.029 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.029 | |
| negative regulation of cell motility | GO:2000146 | 61 | 0.029 | |
| septum transversum development | GO:0003343 | 2 | 0.029 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.028 | |
| regulation of neurotransmitter levels | GO:0001505 | 87 | 0.028 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.028 | |
| positive regulation of heart contraction | GO:0045823 | 14 | 0.028 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.028 | |
| body fluid secretion | GO:0007589 | 53 | 0.028 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.028 | |
| nephron tubule development | GO:0072080 | 84 | 0.028 | |
| immune effector process | GO:0002252 | 321 | 0.028 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.028 | |
| glucose homeostasis | GO:0042593 | 128 | 0.028 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.028 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.028 | |
| neural tube development | GO:0021915 | 160 | 0.028 | |
| cardiac muscle cell action potential | GO:0086001 | 11 | 0.028 | |
| hematopoietic stem cell differentiation | GO:0060218 | 8 | 0.028 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.028 | |
| regulation of inward rectifier potassium channel activity | GO:1901979 | 1 | 0.028 | |
| lipid oxidation | GO:0034440 | 29 | 0.028 | |
| formation of organ boundary | GO:0010160 | 1 | 0.028 | |
| lipid catabolic process | GO:0016042 | 69 | 0.027 | |
| response to radiation | GO:0009314 | 165 | 0.027 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.027 | |
| response to hypoxia | GO:0001666 | 58 | 0.027 | |
| regulation of organ growth | GO:0046620 | 61 | 0.027 | |
| negative regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035359 | 3 | 0.027 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.027 | |
| atrioventricular node development | GO:0003162 | 3 | 0.027 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.027 | |
| bone development | GO:0060348 | 120 | 0.026 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.026 | |
| lipid localization | GO:0010876 | 126 | 0.026 | |
| anion transport | GO:0006820 | 177 | 0.026 | |
| prostate gland development | GO:0030850 | 48 | 0.026 | |
| skeletal system development | GO:0001501 | 356 | 0.026 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.026 | |
| gtp catabolic process | GO:0006184 | 143 | 0.026 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.026 | |
| regulation of cell growth | GO:0001558 | 91 | 0.026 | |
| insulin like growth factor receptor signaling pathway | GO:0048009 | 21 | 0.026 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.026 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.025 | |
| male gonad development | GO:0008584 | 88 | 0.025 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.025 | |
| cellular response to peptide | GO:1901653 | 92 | 0.025 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.025 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.025 | |
